Eurofins Scientific Revenue vs. Debt To Equity
| ERF Stock | EUR 46.79 0.17 0.36% |
For Eurofins Scientific profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Eurofins Scientific to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Eurofins Scientific SE utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Eurofins Scientific's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Eurofins Scientific SE over time as well as its relative position and ranking within its peers.
Eurofins |
Eurofins Scientific Debt To Equity vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Eurofins Scientific's current stock value. Our valuation model uses many indicators to compare Eurofins Scientific value to that of its competitors to determine the firm's financial worth. Eurofins Scientific SE is rated as one of the top companies in revenue category among its peers. It also is one of the top stocks in debt to equity category among its peers . The ratio of Revenue to Debt To Equity for Eurofins Scientific SE is about 57,961,173 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Eurofins Scientific by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Eurofins Scientific's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Eurofins Revenue vs. Competition
Eurofins Scientific SE is rated as one of the top companies in revenue category among its peers. Market size based on revenue of Diagnostics & Research industry is currently estimated at about 29.25 Billion. Eurofins Scientific totals roughly 6.72 Billion in revenue claiming about 23% of equities under Diagnostics & Research industry.
Eurofins Debt To Equity vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Eurofins Scientific |
| = | 6.72 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Eurofins Scientific |
| = | 115.90 % |
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Eurofins Debt To Equity Comparison
Eurofins Scientific is currently under evaluation in debt to equity category among its peers.
Eurofins Scientific Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Eurofins Scientific, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Eurofins Scientific will eventually generate negative long term returns. The profitability progress is the general direction of Eurofins Scientific's change in net profit over the period of time. It can combine multiple indicators of Eurofins Scientific, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Eurofins Scientific SE, through its subsidiaries, provides various analytical testing services worldwide. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg. EUROFINS SCIENT operates under Diagnostics Research classification in France and is traded on Paris Stock Exchange. It employs 43819 people.
Eurofins Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Eurofins Scientific. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Eurofins Scientific position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Eurofins Scientific's important profitability drivers and their relationship over time.
Use Eurofins Scientific in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eurofins Scientific position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eurofins Scientific will appreciate offsetting losses from the drop in the long position's value.Eurofins Scientific Pair Trading
Eurofins Scientific SE Pair Trading Analysis
The ability to find closely correlated positions to Eurofins Scientific could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eurofins Scientific when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eurofins Scientific - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eurofins Scientific SE to buy it.
The correlation of Eurofins Scientific is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eurofins Scientific moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eurofins Scientific moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eurofins Scientific can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Eurofins Scientific position
In addition to having Eurofins Scientific in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run High Dividend Yield ETFs Thematic Idea Now
High Dividend Yield ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The High Dividend Yield ETFs theme has 107 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize High Dividend Yield ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Eurofins Stock
To fully project Eurofins Scientific's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Eurofins Scientific at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Eurofins Scientific's income statement, its balance sheet, and the statement of cash flows.